Pediatric Mechanical Circulatory Support
Extracorporeal life support (ECLS) via extracorporeal membrane oxygenation (ECMO) and ventricular assist devices (VADs) has evolved as a therapeutic treatment option for the care of children with severe ventricular dysfunction, refractory to medical and/or surgical therapy. The American Heart Association currently includes ECLS in both the pediatric and the adult algorithms for refractory shock. In this chapter, we review indications for ECLS initiation, history, basic principles and management strategies, complications, and outcomes.
KeywordsExtracorporeal life support (ECLS) Extracorporeal membrane oxygenation (ECMO) Ventricular assist device (VAD) Heart failure Acquired heart disease Congenital heart disease
Conflicts of Interest
Disclosures: The authors have not disclosed any potential conflicts of interest.
- 1.de Caen AR, Maconochie IK, Aickin R, et al. Part 6: pediatric basic life support and pediatric advanced life support: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation. 2015;132(16 Suppl 1):S177–203.CrossRefGoogle Scholar
- 5.ELSO. Registry of the extracorporeal life support organization. Ann Arbor, MI: ELSO; 2017. http://www.elsonet.org. Accessed 25 Apr 2017.
- 8.Fuchs A, Netz H. Ventricular assist devices in pediatrics. Images Pediatr Cardiol. 2001;3(4):24–54.Google Scholar